Share Price and Basic Stock Data
Last Updated: February 16, 2026, 8:25 pm
| PEG Ratio | 1.64 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Grauer & Weil (India) Ltd operates in the specialty chemicals segment, reporting a market capitalization of ₹3,293 Cr and a current share price of ₹72.6. The company has demonstrated a robust growth trajectory in its revenue, with sales rising from ₹768 Cr in FY 2022 to ₹981 Cr in FY 2023, and further increasing to ₹1,068 Cr in FY 2024. The trailing twelve months (TTM) revenue stood at ₹1,159 Cr, reflecting a healthy upward trend. Quarterly sales figures reveal fluctuations, with a peak of ₹333 Cr in March 2024, followed by a slight decline to ₹264 Cr in June 2024. However, the revenue trend indicates resilience, with sales recovering to ₹285 Cr by December 2023 and expected stability in the coming quarters. Overall, the company has recorded substantial growth, capitalizing on the increasing demand for specialty chemicals in various sectors, including automotive and construction.
Profitability and Efficiency Metrics
Grauer & Weil reported a net profit of ₹151 Cr, with a net profit margin of 13.86% for FY 2025, indicating strong profitability relative to its revenue. The operating profit margin (OPM) stood at 17% for FY 2025, which aligns with sector norms but indicates a slight decline from previous years. The company recorded an impressive return on equity (ROE) of 17.6% and a return on capital employed (ROCE) of 23.3%, showcasing effective utilization of shareholder funds and capital. Despite fluctuations in quarterly operating profit, which peaked at ₹67 Cr in June 2024, and a notable dip to ₹30 Cr in March 2025, the overall profitability metrics remain solid. The interest coverage ratio (ICR) of 85.67x underscores Grauer & Weil’s capability to meet its interest obligations, reflecting financial prudence and operational efficiency.
Balance Sheet Strength and Financial Ratios
The balance sheet of Grauer & Weil demonstrates notable strength, with total assets recorded at ₹1,286 Cr and total liabilities at ₹1,286 Cr, indicating a balanced financial structure. The company maintains minimal borrowings of just ₹12 Cr, resulting in a debt-to-equity ratio of 0.01, which is significantly lower than industry averages, highlighting its low leverage and financial stability. Reserves have steadily increased, reaching ₹952 Cr in September 2025, which supports future growth initiatives. The current ratio of 3.15x and quick ratio of 2.63x suggest a strong liquidity position, enabling the company to meet short-term liabilities comfortably. Furthermore, Grauer & Weil’s price-to-book value (P/BV) ratio stands at 3.96x, indicating a premium valuation compared to typical sector ranges, reflecting investor confidence in the company’s growth prospects.
Shareholding Pattern and Investor Confidence
Grauer & Weil’s shareholding structure reveals a strong promoter holding of 69.03%, which is consistent and stable over recent quarters, indicating a solid commitment from the management. The foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold negligible stakes of 0.59% and 0.02%, respectively, suggesting limited institutional interest. Public shareholding constitutes 30.35%, reflecting a diverse investor base with 54,606 shareholders as of December 2025. This distribution may indicate a potential area for growth in attracting institutional investors. The gradual increase in the number of shareholders from 41,146 in March 2023 to 54,606 in December 2025 suggests rising retail interest and confidence in the company’s performance and future prospects.
Outlook, Risks, and Final Insight
Looking ahead, Grauer & Weil is positioned for continued growth, driven by its strong market presence and expanding product offerings in the specialty chemicals sector. However, the company faces several risks, including potential volatility in raw material prices and fluctuations in demand due to macroeconomic factors. Additionally, the limited institutional investor participation may affect liquidity and share price stability. On the positive side, the company’s low debt levels and strong profitability metrics provide a solid foundation for future growth. If Grauer & Weil successfully navigates these challenges, it can leverage its robust operational efficiency and financial strength to enhance shareholder value. Overall, while the company’s growth trajectory appears promising, careful monitoring of market conditions and operational performance will be essential for sustained success.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 349 Cr. | 38.1 | 61.0/35.0 | 25.1 | 20.5 | 1.05 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 29.0 Cr. | 59.1 | 88.8/52.0 | 14.1 | 89.6 | 1.69 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 46.4 Cr. | 683 | 899/600 | 15.6 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,178 Cr. | 70.1 | 111/68.2 | 22.7 | 22.0 | 0.71 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 599 Cr. | 240 | 350/208 | 22.9 | 93.8 | 1.04 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,962.36 Cr | 733.20 | 84.09 | 182.87 | 0.47% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 205 | 251 | 327 | 200 | 250 | 285 | 333 | 264 | 255 | 275 | 340 | 253 | 291 |
| Expenses | 166 | 204 | 297 | 152 | 202 | 230 | 294 | 200 | 212 | 222 | 311 | 201 | 248 |
| Operating Profit | 39 | 47 | 30 | 48 | 49 | 55 | 39 | 64 | 43 | 52 | 30 | 53 | 43 |
| OPM % | 19% | 19% | 9% | 24% | 20% | 19% | 12% | 24% | 17% | 19% | 9% | 21% | 15% |
| Other Income | 4 | 5 | 4 | 6 | 7 | 9 | 8 | 8 | 14 | 12 | 12 | 13 | 11 |
| Interest | -0 | 1 | 1 | 0 | 0 | 0 | 3 | 0 | 0 | 1 | 2 | 1 | 0 |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 |
| Profit before tax | 38 | 47 | 29 | 48 | 51 | 58 | 39 | 67 | 51 | 58 | 34 | 58 | 48 |
| Tax % | 26% | 26% | 25% | 23% | 26% | 26% | 26% | 24% | 26% | 26% | 25% | 25% | 20% |
| Net Profit | 28 | 34 | 22 | 37 | 37 | 43 | 29 | 51 | 38 | 43 | 26 | 44 | 39 |
| EPS in Rs | 0.62 | 0.76 | 0.48 | 0.81 | 0.83 | 0.94 | 0.64 | 1.12 | 0.83 | 0.95 | 0.57 | 0.96 | 0.85 |
Last Updated: December 26, 2025, 5:16 pm
Below is a detailed analysis of the quarterly data for Grauer & Weil (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 291.00 Cr.. The value appears strong and on an upward trend. It has increased from 253.00 Cr. (Jun 2025) to 291.00 Cr., marking an increase of 38.00 Cr..
- For Expenses, as of Sep 2025, the value is 248.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 201.00 Cr. (Jun 2025) to 248.00 Cr., marking an increase of 47.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 43.00 Cr.. The value appears to be declining and may need further review. It has decreased from 53.00 Cr. (Jun 2025) to 43.00 Cr., marking a decrease of 10.00 Cr..
- For OPM %, as of Sep 2025, the value is 15.00%. The value appears to be declining and may need further review. It has decreased from 21.00% (Jun 2025) to 15.00%, marking a decrease of 6.00%.
- For Other Income, as of Sep 2025, the value is 11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Jun 2025) to 11.00 Cr., marking a decrease of 2.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.00 Cr. (Jun 2025) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 6.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 48.00 Cr.. The value appears to be declining and may need further review. It has decreased from 58.00 Cr. (Jun 2025) to 48.00 Cr., marking a decrease of 10.00 Cr..
- For Tax %, as of Sep 2025, the value is 20.00%. The value appears to be improving (decreasing) as expected. It has decreased from 25.00% (Jun 2025) to 20.00%, marking a decrease of 5.00%.
- For Net Profit, as of Sep 2025, the value is 39.00 Cr.. The value appears to be declining and may need further review. It has decreased from 44.00 Cr. (Jun 2025) to 39.00 Cr., marking a decrease of 5.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.85. The value appears to be declining and may need further review. It has decreased from 0.96 (Jun 2025) to 0.85, marking a decrease of 0.11.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:37 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 380 | 409 | 413 | 432 | 497 | 600 | 618 | 605 | 768 | 981 | 1,068 | 1,134 | 1,159 |
| Expenses | 319 | 333 | 335 | 346 | 400 | 494 | 521 | 505 | 655 | 825 | 877 | 944 | 982 |
| Operating Profit | 61 | 76 | 78 | 86 | 98 | 106 | 97 | 101 | 114 | 156 | 191 | 189 | 178 |
| OPM % | 16% | 19% | 19% | 20% | 20% | 18% | 16% | 17% | 15% | 16% | 18% | 17% | 15% |
| Other Income | 3 | 1 | 2 | 4 | 10 | 5 | 20 | 15 | 16 | 18 | 31 | 46 | 48 |
| Interest | 17 | 14 | 10 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 5 | 4 | 3 |
| Depreciation | 12 | 16 | 14 | 14 | 15 | 15 | 19 | 18 | 20 | 20 | 21 | 22 | 24 |
| Profit before tax | 35 | 46 | 56 | 73 | 91 | 94 | 95 | 94 | 107 | 152 | 196 | 210 | 199 |
| Tax % | 14% | 28% | 24% | 26% | 30% | 32% | 21% | 27% | 26% | 26% | 25% | 25% | |
| Net Profit | 30 | 33 | 42 | 54 | 64 | 64 | 76 | 69 | 79 | 113 | 146 | 157 | 151 |
| EPS in Rs | 0.67 | 0.74 | 0.93 | 1.20 | 1.41 | 1.41 | 1.67 | 1.52 | 1.74 | 2.49 | 3.23 | 3.47 | 3.33 |
| Dividend Payout % | 12% | 15% | 15% | 17% | 21% | 21% | 15% | 16% | 19% | 16% | 8% | 14% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 10.00% | 27.27% | 28.57% | 18.52% | 0.00% | 18.75% | -9.21% | 14.49% | 43.04% | 29.20% | 7.53% |
| Change in YoY Net Profit Growth (%) | 0.00% | 17.27% | 1.30% | -10.05% | -18.52% | 18.75% | -27.96% | 23.70% | 28.55% | -13.83% | -21.67% |
Grauer & Weil (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 13% |
| 3 Years: | 14% |
| TTM: | -1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 17% |
| 3 Years: | 26% |
| TTM: | -6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 35% |
| 3 Years: | 40% |
| 1 Year: | -11% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 17% |
| 3 Years: | 18% |
| Last Year: | 18% |
Last Updated: September 5, 2025, 3:40 pm
Balance Sheet
Last Updated: December 4, 2025, 2:59 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 45 | 45 |
| Reserves | 171 | 194 | 228 | 278 | 331 | 379 | 422 | 491 | 560 | 657 | 783 | 894 | 952 |
| Borrowings | 97 | 68 | 27 | 20 | 7 | 21 | 23 | 22 | 25 | 24 | 27 | 12 | 12 |
| Other Liabilities | 133 | 125 | 119 | 133 | 146 | 159 | 174 | 214 | 217 | 251 | 292 | 334 | 319 |
| Total Liabilities | 423 | 410 | 397 | 454 | 507 | 581 | 642 | 750 | 824 | 954 | 1,124 | 1,286 | 1,328 |
| Fixed Assets | 225 | 216 | 210 | 212 | 206 | 231 | 241 | 238 | 247 | 244 | 243 | 254 | 269 |
| CWIP | 1 | 0 | 0 | 0 | 0 | 3 | 1 | 4 | 1 | 3 | 14 | 27 | 20 |
| Investments | 3 | 2 | 1 | 1 | 3 | 1 | 0 | 0 | 1 | 17 | 49 | 71 | 407 |
| Other Assets | 194 | 192 | 186 | 241 | 297 | 346 | 399 | 508 | 576 | 690 | 817 | 934 | 633 |
| Total Assets | 423 | 410 | 397 | 454 | 507 | 581 | 642 | 750 | 824 | 954 | 1,124 | 1,286 | 1,328 |
Below is a detailed analysis of the balance sheet data for Grauer & Weil (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 45.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 45.00 Cr..
- For Reserves, as of Sep 2025, the value is 952.00 Cr.. The value appears strong and on an upward trend. It has increased from 894.00 Cr. (Mar 2025) to 952.00 Cr., marking an increase of 58.00 Cr..
- For Borrowings, as of Sep 2025, the value is 12.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 12.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 319.00 Cr.. The value appears to be improving (decreasing). It has decreased from 334.00 Cr. (Mar 2025) to 319.00 Cr., marking a decrease of 15.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,328.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,286.00 Cr. (Mar 2025) to 1,328.00 Cr., marking an increase of 42.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 269.00 Cr.. The value appears strong and on an upward trend. It has increased from 254.00 Cr. (Mar 2025) to 269.00 Cr., marking an increase of 15.00 Cr..
- For CWIP, as of Sep 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 27.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 7.00 Cr..
- For Investments, as of Sep 2025, the value is 407.00 Cr.. The value appears strong and on an upward trend. It has increased from 71.00 Cr. (Mar 2025) to 407.00 Cr., marking an increase of 336.00 Cr..
- For Other Assets, as of Sep 2025, the value is 633.00 Cr.. The value appears to be declining and may need further review. It has decreased from 934.00 Cr. (Mar 2025) to 633.00 Cr., marking a decrease of 301.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,328.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,286.00 Cr. (Mar 2025) to 1,328.00 Cr., marking an increase of 42.00 Cr..
Notably, the Reserves (952.00 Cr.) exceed the Borrowings (12.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -36.00 | 8.00 | 51.00 | 66.00 | 91.00 | 85.00 | 74.00 | 79.00 | 89.00 | 132.00 | 164.00 | 177.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 89 | 80 | 70 | 63 | 65 | 68 | 67 | 77 | 62 | 68 | 63 | 64 |
| Inventory Days | 109 | 120 | 115 | 118 | 100 | 106 | 126 | 108 | 121 | 83 | 90 | 98 |
| Days Payable | 79 | 67 | 68 | 82 | 81 | 68 | 95 | 110 | 91 | 77 | 86 | 90 |
| Cash Conversion Cycle | 119 | 133 | 117 | 99 | 83 | 106 | 99 | 75 | 92 | 75 | 68 | 72 |
| Working Capital Days | 17 | 26 | 50 | 38 | 49 | 56 | 57 | 36 | 49 | 43 | 34 | 32 |
| ROCE % | 18% | 21% | 24% | 25% | 27% | 26% | 20% | 19% | 19% | 24% | 26% | 23% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 3.47 | 6.45 | 4.98 | 3.47 | 3.04 |
| Diluted EPS (Rs.) | 3.47 | 6.45 | 4.98 | 3.47 | 3.04 |
| Cash EPS (Rs.) | 3.96 | 7.38 | 5.86 | 4.34 | 3.85 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 20.72 | 35.52 | 29.96 | 25.69 | 22.67 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 20.72 | 35.52 | 29.96 | 25.69 | 22.67 |
| Revenue From Operations / Share (Rs.) | 25.00 | 47.15 | 43.31 | 33.89 | 26.72 |
| PBDIT / Share (Rs.) | 5.18 | 9.77 | 7.69 | 5.58 | 5.07 |
| PBIT / Share (Rs.) | 4.68 | 8.84 | 6.82 | 4.71 | 4.26 |
| PBT / Share (Rs.) | 4.62 | 8.66 | 6.70 | 4.71 | 4.16 |
| Net Profit / Share (Rs.) | 3.47 | 6.45 | 4.98 | 3.47 | 3.04 |
| NP After MI And SOA / Share (Rs.) | 3.47 | 6.45 | 4.98 | 3.47 | 3.04 |
| PBDIT Margin (%) | 20.70 | 20.71 | 17.75 | 16.45 | 18.97 |
| PBIT Margin (%) | 18.73 | 18.74 | 15.74 | 13.90 | 15.93 |
| PBT Margin (%) | 18.48 | 18.35 | 15.47 | 13.89 | 15.57 |
| Net Profit Margin (%) | 13.86 | 13.68 | 11.50 | 10.24 | 11.37 |
| NP After MI And SOA Margin (%) | 13.86 | 13.68 | 11.50 | 10.25 | 11.35 |
| Return on Networth / Equity (%) | 16.73 | 18.16 | 16.62 | 13.52 | 13.38 |
| Return on Capital Employeed (%) | 21.47 | 23.24 | 21.11 | 16.88 | 16.97 |
| Return On Assets (%) | 12.22 | 12.99 | 11.83 | 9.55 | 9.17 |
| Total Debt / Equity (X) | 0.01 | 0.02 | 0.02 | 0.03 | 0.03 |
| Asset Turnover Ratio (%) | 0.94 | 1.03 | 1.10 | 0.97 | 0.86 |
| Current Ratio (X) | 3.15 | 3.16 | 2.87 | 2.89 | 2.75 |
| Quick Ratio (X) | 2.63 | 2.64 | 2.30 | 2.14 | 2.24 |
| Inventory Turnover Ratio (X) | 7.71 | 4.22 | 4.11 | 3.81 | 3.03 |
| Dividend Payout Ratio (NP) (%) | 14.42 | 22.47 | 13.04 | 14.38 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 12.62 | 19.63 | 11.09 | 11.51 | 0.00 |
| Earning Retention Ratio (%) | 85.58 | 77.53 | 86.96 | 85.62 | 0.00 |
| Cash Earning Retention Ratio (%) | 87.38 | 80.37 | 88.91 | 88.49 | 0.00 |
| Interest Coverage Ratio (X) | 85.67 | 53.77 | 93.63 | 50.36 | 53.33 |
| Interest Coverage Ratio (Post Tax) (X) | 58.37 | 36.51 | 62.04 | 31.37 | 32.99 |
| Enterprise Value (Cr.) | 3259.26 | 3602.56 | 1964.44 | 1088.88 | 653.83 |
| EV / Net Operating Revenue (X) | 2.87 | 3.37 | 2.00 | 1.42 | 1.08 |
| EV / EBITDA (X) | 13.88 | 16.27 | 11.27 | 8.61 | 5.69 |
| MarketCap / Net Operating Revenue (X) | 3.28 | 3.74 | 2.27 | 1.73 | 1.47 |
| Retention Ratios (%) | 85.57 | 77.52 | 86.95 | 85.61 | 0.00 |
| Price / BV (X) | 3.96 | 4.97 | 3.29 | 2.28 | 1.73 |
| Price / Net Operating Revenue (X) | 3.28 | 3.74 | 2.27 | 1.73 | 1.47 |
| EarningsYield | 0.04 | 0.03 | 0.05 | 0.05 | 0.07 |
After reviewing the key financial ratios for Grauer & Weil (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.47. This value is below the healthy minimum of 5. It has decreased from 6.45 (Mar 24) to 3.47, marking a decrease of 2.98.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.47. This value is below the healthy minimum of 5. It has decreased from 6.45 (Mar 24) to 3.47, marking a decrease of 2.98.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.96. This value is within the healthy range. It has decreased from 7.38 (Mar 24) to 3.96, marking a decrease of 3.42.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 20.72. It has decreased from 35.52 (Mar 24) to 20.72, marking a decrease of 14.80.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 20.72. It has decreased from 35.52 (Mar 24) to 20.72, marking a decrease of 14.80.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 25.00. It has decreased from 47.15 (Mar 24) to 25.00, marking a decrease of 22.15.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 5.18. This value is within the healthy range. It has decreased from 9.77 (Mar 24) to 5.18, marking a decrease of 4.59.
- For PBIT / Share (Rs.), as of Mar 25, the value is 4.68. This value is within the healthy range. It has decreased from 8.84 (Mar 24) to 4.68, marking a decrease of 4.16.
- For PBT / Share (Rs.), as of Mar 25, the value is 4.62. This value is within the healthy range. It has decreased from 8.66 (Mar 24) to 4.62, marking a decrease of 4.04.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.47. This value is within the healthy range. It has decreased from 6.45 (Mar 24) to 3.47, marking a decrease of 2.98.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.47. This value is within the healthy range. It has decreased from 6.45 (Mar 24) to 3.47, marking a decrease of 2.98.
- For PBDIT Margin (%), as of Mar 25, the value is 20.70. This value is within the healthy range. It has decreased from 20.71 (Mar 24) to 20.70, marking a decrease of 0.01.
- For PBIT Margin (%), as of Mar 25, the value is 18.73. This value is within the healthy range. It has decreased from 18.74 (Mar 24) to 18.73, marking a decrease of 0.01.
- For PBT Margin (%), as of Mar 25, the value is 18.48. This value is within the healthy range. It has increased from 18.35 (Mar 24) to 18.48, marking an increase of 0.13.
- For Net Profit Margin (%), as of Mar 25, the value is 13.86. This value exceeds the healthy maximum of 10. It has increased from 13.68 (Mar 24) to 13.86, marking an increase of 0.18.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 13.86. This value is within the healthy range. It has increased from 13.68 (Mar 24) to 13.86, marking an increase of 0.18.
- For Return on Networth / Equity (%), as of Mar 25, the value is 16.73. This value is within the healthy range. It has decreased from 18.16 (Mar 24) to 16.73, marking a decrease of 1.43.
- For Return on Capital Employeed (%), as of Mar 25, the value is 21.47. This value is within the healthy range. It has decreased from 23.24 (Mar 24) to 21.47, marking a decrease of 1.77.
- For Return On Assets (%), as of Mar 25, the value is 12.22. This value is within the healthy range. It has decreased from 12.99 (Mar 24) to 12.22, marking a decrease of 0.77.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.94. It has decreased from 1.03 (Mar 24) to 0.94, marking a decrease of 0.09.
- For Current Ratio (X), as of Mar 25, the value is 3.15. This value exceeds the healthy maximum of 3. It has decreased from 3.16 (Mar 24) to 3.15, marking a decrease of 0.01.
- For Quick Ratio (X), as of Mar 25, the value is 2.63. This value exceeds the healthy maximum of 2. It has decreased from 2.64 (Mar 24) to 2.63, marking a decrease of 0.01.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.71. This value is within the healthy range. It has increased from 4.22 (Mar 24) to 7.71, marking an increase of 3.49.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 14.42. This value is below the healthy minimum of 20. It has decreased from 22.47 (Mar 24) to 14.42, marking a decrease of 8.05.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 12.62. This value is below the healthy minimum of 20. It has decreased from 19.63 (Mar 24) to 12.62, marking a decrease of 7.01.
- For Earning Retention Ratio (%), as of Mar 25, the value is 85.58. This value exceeds the healthy maximum of 70. It has increased from 77.53 (Mar 24) to 85.58, marking an increase of 8.05.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 87.38. This value exceeds the healthy maximum of 70. It has increased from 80.37 (Mar 24) to 87.38, marking an increase of 7.01.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 85.67. This value is within the healthy range. It has increased from 53.77 (Mar 24) to 85.67, marking an increase of 31.90.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 58.37. This value is within the healthy range. It has increased from 36.51 (Mar 24) to 58.37, marking an increase of 21.86.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,259.26. It has decreased from 3,602.56 (Mar 24) to 3,259.26, marking a decrease of 343.30.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.87. This value is within the healthy range. It has decreased from 3.37 (Mar 24) to 2.87, marking a decrease of 0.50.
- For EV / EBITDA (X), as of Mar 25, the value is 13.88. This value is within the healthy range. It has decreased from 16.27 (Mar 24) to 13.88, marking a decrease of 2.39.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.28. This value exceeds the healthy maximum of 3. It has decreased from 3.74 (Mar 24) to 3.28, marking a decrease of 0.46.
- For Retention Ratios (%), as of Mar 25, the value is 85.57. This value exceeds the healthy maximum of 70. It has increased from 77.52 (Mar 24) to 85.57, marking an increase of 8.05.
- For Price / BV (X), as of Mar 25, the value is 3.96. This value exceeds the healthy maximum of 3. It has decreased from 4.97 (Mar 24) to 3.96, marking a decrease of 1.01.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.28. This value exceeds the healthy maximum of 3. It has decreased from 3.74 (Mar 24) to 3.28, marking a decrease of 0.46.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Grauer & Weil (India) Ltd:
- Net Profit Margin: 13.86%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 21.47% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.73% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 58.37
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.63
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 22.7 (Industry average Stock P/E: 84.09)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 13.86%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Growel Corporate, Mumbai Maharashtra 400101 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Umeshkumar More | Chairman |
| Mr. Nirajkumar More | Managing Director |
| Mr. Rohitkumar More | Whole Time Director |
| Mr. Yogesh Samat | Whole Time Director |
| Dr. Prerna Goradia | Independent Director |
| Mr. Ayush Agarwala | Independent Director |
| Mr. Ashok Kumar Kanodia | Independent Director |
| Mr. Anil Gadodia | Independent Director |
FAQ
What is the intrinsic value of Grauer & Weil (India) Ltd?
Grauer & Weil (India) Ltd's intrinsic value (as of 16 February 2026) is ₹80.63 which is 15.02% higher the current market price of ₹70.10, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹3,178 Cr. market cap, FY2025-2026 high/low of ₹111/68.2, reserves of ₹952 Cr, and liabilities of ₹1,328 Cr.
What is the Market Cap of Grauer & Weil (India) Ltd?
The Market Cap of Grauer & Weil (India) Ltd is 3,178 Cr..
What is the current Stock Price of Grauer & Weil (India) Ltd as on 16 February 2026?
The current stock price of Grauer & Weil (India) Ltd as on 16 February 2026 is ₹70.1.
What is the High / Low of Grauer & Weil (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Grauer & Weil (India) Ltd stocks is ₹111/68.2.
What is the Stock P/E of Grauer & Weil (India) Ltd?
The Stock P/E of Grauer & Weil (India) Ltd is 22.7.
What is the Book Value of Grauer & Weil (India) Ltd?
The Book Value of Grauer & Weil (India) Ltd is 22.0.
What is the Dividend Yield of Grauer & Weil (India) Ltd?
The Dividend Yield of Grauer & Weil (India) Ltd is 0.71 %.
What is the ROCE of Grauer & Weil (India) Ltd?
The ROCE of Grauer & Weil (India) Ltd is 23.3 %.
What is the ROE of Grauer & Weil (India) Ltd?
The ROE of Grauer & Weil (India) Ltd is 17.6 %.
What is the Face Value of Grauer & Weil (India) Ltd?
The Face Value of Grauer & Weil (India) Ltd is 1.00.